Related references
Note: Only part of the references are listed.Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma ≤3 cm in diameter
Ling-Ling He et al.
GASTROENTEROLOGY REPORT (2019)
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2019)
PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma
Xiaoli Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection
Giovanni Marasco et al.
JOURNAL OF HEPATOLOGY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories
Kyle J. Foreman et al.
LANCET (2018)
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
David J. Pinato et al.
JOURNAL OF HEPATOLOGY (2017)
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Gonzalo Sapisochin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Validation and ranking of seven staging systems of hepatocellular carcinoma
Zhan-Hong Chen et al.
ONCOLOGY LETTERS (2017)
Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant
Neil Mehta et al.
JAMA ONCOLOGY (2017)
Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents
E. D. Saad et al.
ANNALS OF ONCOLOGY (2016)
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
Alexander Martens et al.
CLINICAL CANCER RESEARCH (2016)
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems
Po-Hong Liu et al.
JOURNAL OF HEPATOLOGY (2016)
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
Andrew Gabrielson et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Prognostic Nomograms for Prediction of Recurrence and Survival After Curative Liver Resection for Hepatocellular Carcinoma
Ju Hyun Shim et al.
ANNALS OF SURGERY (2015)
Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
Kelong Han et al.
NEURO-ONCOLOGY (2014)
CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
Hye-Jung Kim et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Artificial neural networks in medical diagnosis
Filippo Amato et al.
JOURNAL OF APPLIED BIOMEDICINE (2013)
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
Shuichiro Shiina et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
CD4 T Cells Promote CD8 T Cell Immunity at the Priming and Effector Site during Viral Encephalitis
Timothy W. Phares et al.
JOURNAL OF VIROLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
Fidel-David Huitzil-Melendez et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Staging of hepatocellular carcinoma - Assessment of the Japanese TNM and AICCIUICC TNM systems in a cohort of 13,772 patients in Japan
Masami Minagawa et al.
ANNALS OF SURGERY (2007)
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
M Kudo et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the Liver Italian Program staging system - A study based on 926 patients
TWT Leung et al.
CANCER (2002)
Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research
S Agatonovic-Kustrin et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2000)
Share Paper
